Legal Representation
Attorney
Clemens W. Pauly
USPTO Deadlines
Next Deadline
1024 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20221011)
Due Date
October 11, 2028
Grace Period Ends
April 11, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 21, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jan 30, 2023 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Jan 30, 2023 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| Jan 11, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Oct 11, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 11, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 25, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jul 7, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jul 6, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jul 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 22, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 4, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 4, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 4, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 6, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jan 18, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jan 18, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Dec 23, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 22, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 15, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 1, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 16, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Medical and scientific research and data analysis services; implementation and analysis of clinical trials in the field of medicines, medical devices, biotechnology and natural sciences; development of protocols, scientific consultation, and preparation of reports with respect to medical research; research center project management; local and global clinical trial project management; pharmaceutical drug development services, development of clinical trial methodologies; consultancy services in the field of pharmaceutical clinical trials; extensive clinical research services for others; electronic storage services for clinical trial data; biostatic analysis; services provided by consultants with respect to research in the field of environmental protection, preclinical research and evaluation of pharmaceutical product development; conducting clinical trials for others in the nature of scientific research, especially the correction of clinical trials and defective records; clinical trial services in the nature of strategic management of clinical research portfolios and follow-up of biological monitoring; providing information in the field of natural sciences and scientific research to physicians and other health professionals, to patients and to medical, pharmaceutical and biotechnological companies; providing technical drafting services for complaints and/or disputes in the field of medical research and clinical studies; consultation services in the field of clinical research under contract and product development under contact; design and development of computer hardware as well as consultation services relating thereto for others; creating websites featuring blogs on medical and pharmaceutical information relating to chronic conditions and diseases; creating and maintaining Internet websites for patients and registered care providers to form virtual communities and to engage in the field of health; design and development of an interactive software for use in the communication and dissemination of medical and pharmaceutical information
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The sign consists of the word SCIRENT, in Latin capital letters, in black. Below the word SCIRENT, there are four words - Clinical Research and Science, in Latin letters, in blue. In the upper right corner, above the word SCIRENT there is a circle in different shades of green and blue (light green, dark green, light blue, dark blue) whose center is painted in white
Color Claim
The color(s) white, black, blue and green is/are claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CLINICAL RESEARCH AND SCIENCE"